Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)-Reference-Cited by-同舟云学术

Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)

Published:2014-11 Issue:5 Volume:146 Page:1274-1285
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Bonderman Diana,Pretsch Ingrid,Steringer-Mascherbauer Regina,Jansa Pavel,Rosenkranz Stephan,Tufaro Caroline,Bojic Andja,Lam Carolyn S. P,Frey Reiner,Ochan Kilama Michael,Unger Sigrun,Roessig Lothar,Lang Irene M

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference36 articles.

1. Trends in prevalence and outcome of heart failure with preserved ejection fraction;Owan;N Engl J Med,2006

2. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

3. Diastolic heart failure—abnormalities in active relaxation and passive stiffness of the left ventricle;Zile;N Engl J Med,2004

4. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction;Borlaug;J Am Coll Cardiol,2010

5. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations;Kawaguchi;Circulation,2003

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary hypertension associated to left heart disease: Phenotypes and treatment;European Journal of Internal Medicine;2024-08

2. Pulmonary artery denervation versus conventional therapies for PAH: a systematic review and updated network meta‐analysis;ESC Heart Failure;2024-05-23

3. Exploring the therapeutic potential of tetrahydrobiopterin for heart failure with preserved ejection fraction: A path forward;Life Sciences;2024-05

4. Evaluating haemodynamic changes: vericiguat in patients with heart failure with reduced ejection fraction;ESC Heart Failure;2024-04-29

5. Cardiovascular Effects of Stimulators of Soluble Guanylate Cyclase Administration: A Meta-analysis of Randomized Controlled Trials;Current Atherosclerosis Reports;2024-04-02